Geode Capital Management’s TScan Therapeutics TCRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $822K | Sell |
566,371
-448,719
| -44% | -$651K | ﹤0.01% | 3393 |
|
|
2025
Q1 | $1.4M | Buy |
1,015,090
+51,833
| +5% | +$71.5K | ﹤0.01% | 3181 |
|
|
2024
Q4 | $2.93M | Sell |
963,257
-10,209
| -1% | -$31K | ﹤0.01% | 2991 |
|
|
2024
Q3 | $4.85M | Buy |
973,466
+72,967
| +8% | +$363K | ﹤0.01% | 2772 |
|
|
2024
Q2 | $5.27M | Buy |
900,499
+486,720
| +118% | +$2.85M | ﹤0.01% | 2690 |
|
|
2024
Q1 | $3.29M | Buy |
413,779
+22,133
| +6% | +$176K | ﹤0.01% | 2910 |
|
|
2023
Q4 | $2.28M | Buy |
391,646
+83,708
| +27% | +$488K | ﹤0.01% | 3053 |
|
|
2023
Q3 | $789K | Buy |
307,938
+191,047
| +163% | +$489K | ﹤0.01% | 3421 |
|
|
2023
Q2 | $292K | Buy |
116,891
+16,449
| +16% | +$41.1K | ﹤0.01% | 3869 |
|
|
2023
Q1 | $211K | Hold |
100,442
| – | – | ﹤0.01% | 4022 |
|
|
2022
Q4 | $163K | Sell |
100,442
-227
| -0.2% | -$368 | ﹤0.01% | 4204 |
|
|
2022
Q3 | $307K | Buy |
100,669
+66,568
| +195% | +$203K | ﹤0.01% | 3976 |
|
|
2022
Q2 | $107K | Buy |
34,101
+942
| +3% | +$2.96K | ﹤0.01% | 4566 |
|
|
2022
Q1 | $92K | Buy |
33,159
+7,738
| +30% | +$21.5K | ﹤0.01% | 4688 |
|
|
2021
Q4 | $114K | Buy |
25,421
+12,635
| +99% | +$56.7K | ﹤0.01% | 4691 |
|
|
2021
Q3 | $106K | Buy |
+12,786
| New | +$106K | ﹤0.01% | 4655 |
|